34.49
price up icon2.10%   0.71
after-market アフターアワーズ: 34.30 -0.19 -0.55%
loading
前日終値:
$33.78
開ける:
$33.88
24時間の取引高:
2.53M
Relative Volume:
1.06
時価総額:
$4.77B
収益:
$181.74M
当期純損益:
$-143.97M
株価収益率:
-24.81
EPS:
-1.39
ネットキャッシュフロー:
$9.60M
1週間 パフォーマンス:
+6.12%
1か月 パフォーマンス:
+56.56%
6か月 パフォーマンス:
+170.72%
1年 パフォーマンス:
+78.06%
1日の値動き範囲:
Value
$33.55
$34.61
1週間の範囲:
Value
$31.45
$34.61
52週間の値動き範囲:
Value
$9.57
$34.61

Arrowhead Pharmaceuticals Inc Stock (ARWR) Company Profile

Name
名前
Arrowhead Pharmaceuticals Inc
Name
セクター
Healthcare (1147)
Name
電話
626-696-4702
Name
住所
177 E COLORADO BLVD, PASADENA, CA
Name
職員
609
Name
次回の収益日
2025-02-10
Name
最新のSEC提出書
Name
ARWR's Discussions on Twitter

ARWR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ARWR
Arrowhead Pharmaceuticals Inc
34.49 4.67B 181.74M -143.97M 9.60M -1.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Arrowhead Pharmaceuticals Inc Stock (ARWR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-06-05 開始されました Goldman Neutral
2023-12-04 開始されました BofA Securities Buy
2023-09-19 開始されました Citigroup Neutral
2023-07-21 開始されました TD Cowen Outperform
2023-05-12 ダウングレード SVB Securities Outperform → Market Perform
2023-04-26 開始されました SMBC Nikko Outperform
2023-04-12 アップグレード SVB Securities Market Perform → Outperform
2023-03-21 開始されました Bernstein Mkt Perform
2022-09-09 開始されました Morgan Stanley Equal-Weight
2022-05-11 アップグレード Robert W. Baird Neutral → Outperform
2022-01-19 再開されました Goldman Buy
2021-08-06 繰り返されました Chardan Capital Markets Buy
2021-06-04 再開されました Robert W. Baird Neutral
2021-02-05 繰り返されました H.C. Wainwright Buy
2020-12-21 ダウングレード Robert W. Baird Outperform → Neutral
2020-12-16 開始されました UBS Buy
2020-11-19 開始されました Citigroup Buy
2020-05-13 開始されました RBC Capital Mkts Outperform
2020-05-08 アップグレード Oppenheimer Perform → Outperform
2020-04-15 アップグレード Cantor Fitzgerald Neutral → Overweight
2020-03-24 アップグレード SVB Leerink Underperform → Mkt Perform
2020-03-17 開始されました Goldman Neutral
2020-01-21 開始されました SVB Leerink Underperform
2019-12-13 開始されました Oppenheimer Perform
2019-11-29 繰り返されました Chardan Capital Markets Buy
2019-11-27 繰り返されました B. Riley FBR Buy
2019-11-25 アップグレード Robert W. Baird Neutral → Outperform
2019-10-24 ダウングレード Robert W. Baird Outperform → Neutral
2019-10-22 繰り返されました Chardan Capital Markets Buy
2019-10-03 開始されました Robert W. Baird Outperform
2018-09-07 アップグレード B. Riley FBR Neutral → Buy
2018-09-06 繰り返されました Chardan Capital Markets Buy
2018-08-08 繰り返されました Cantor Fitzgerald Overweight
2018-07-02 繰り返されました Chardan Capital Markets Buy
すべてを表示

Arrowhead Pharmaceuticals Inc (ARWR) 最新ニュース

pulisher
Sep 30, 2025

Arrowhead Pharmaceuticals stock hits 52-week high at 34.53 USD By Investing.com - Investing.com Australia

Sep 30, 2025
pulisher
Sep 30, 2025

Arrowhead Pharmaceuticals stock hits 52-week high at 34.53 USD - Investing.com India

Sep 30, 2025
pulisher
Sep 30, 2025

Can Quantum Digital Vision India Ltd Beat EPS Estimates in the Next QuarterDividend Stability Analysis & Stay Safe With Built-In Risk Monitoring - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

Ranking Arrowhead Pharmaceuticals Inc. among high performing stocks via toolsWeekly Risk Report & Consistent Income Trade Recommendations - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Hits New 1-Year HighWhat's Next? - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

13,500 Shares in Arrowhead Pharmaceuticals, Inc. $ARWR Acquired by Moody Lynn & Lieberson LLC - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

What technical models suggest about Arrowhead Pharmaceuticals Inc.’s comebackWeekly Trend Recap & Consistent Profit Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Arrowhead Pharmaceuticals Inc. (ARWR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Sep 30, 2025
pulisher
Sep 29, 2025

Why millennials buy Arrowhead Pharmaceuticals Inc. (HDP1) stockJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

4 Biotechnology Stocks That Outshine In Momentum Amid Strong Technicals - inkl

Sep 29, 2025
pulisher
Sep 29, 2025

Is Arrowhead Pharmaceuticals Inc a good long term investmentEarnings Forecast Updates & Free Significant Capital Appreciation - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

Will Arrowhead Pharmaceuticals Inc. (HDP1) stock outperform small cap peersJuly 2025 Sector Moves & Safe Entry Point Alerts - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about Arrowhead Pharmaceuticals Inc stockGap Up/Gap Down Analysis & Free Rapid Portfolio Appreciation - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Is Arrowhead Pharmaceuticals Inc HDP1 a good long term investmentEarnings Miss Alerts & Capital Allocation Recommendations - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Arrowhead Pharmaceuticals, Inc. $ARWR Stock Position Decreased by Voya Investment Management LLC - MarketBeat

Sep 28, 2025
pulisher
Sep 26, 2025

Will Arrowhead Pharmaceuticals Inc. stock outperform Dow Jones index2025 Support & Resistance & Growth Focused Stock Pick Reports - newser.com

Sep 26, 2025
pulisher
Sep 26, 2025

Can Arrowhead Pharmaceuticals Inc. stock deliver surprise earnings beatQuarterly Profit Report & Growth Focused Entry Reports - newser.com

Sep 26, 2025
pulisher
Sep 25, 2025

Arrowhead Pharmaceuticals Hits New 52-Week High of $33.73 - Markets Mojo

Sep 25, 2025
pulisher
Sep 24, 2025

Arrowhead Pharmaceuticals Hits New 52-Week High at $33.00 - Markets Mojo

Sep 24, 2025
pulisher
Sep 24, 2025

Arrowhead Pharmaceuticals Hits New 52-Week High at $32.17 - Markets Mojo

Sep 24, 2025
pulisher
Sep 24, 2025

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Reaches New 52-Week HighWhat's Next? - MarketBeat

Sep 24, 2025
pulisher
Sep 23, 2025

Piper Sandler Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $45 - 富途牛牛

Sep 23, 2025
pulisher
Sep 23, 2025

H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $80 - 富途牛牛

Sep 23, 2025
pulisher
Sep 23, 2025

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Reaches New 1-Year HighStill a Buy? - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Arrowhead Pharmaceuticals Hits New 52-Week High at $31.67 - Markets Mojo

Sep 22, 2025
pulisher
Sep 22, 2025

Arrowhead Pharmaceuticals stock hits 52-week high at 31.7 USD By Investing.com - Investing.com Canada

Sep 22, 2025
pulisher
Sep 22, 2025

Arrowhead Pharmaceuticals stock hits 52-week high at 31.7 USD - Investing.com

Sep 22, 2025
pulisher
Sep 22, 2025

What is HC Wainwright's Estimate for ARWR FY2025 Earnings? - MarketBeat

Sep 22, 2025
pulisher
Sep 21, 2025

Arrowhead Pharmaceuticals Hits New 52-Week High at $31.62 - Markets Mojo

Sep 21, 2025
pulisher
Sep 21, 2025

Arrowhead Pharmaceuticals Hits Day High with 8.17% Surge in Stock Price - Markets Mojo

Sep 21, 2025
pulisher
Sep 21, 2025

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives $43.14 Average PT from Analysts - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Published on: 2025-09-21 07:04:10 - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Market Recap: What is UBERs revenue forecastQuarterly Growth Report & Smart Investment Allocation Insights - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Breakouts Watch: Can Arrowhead Pharmaceuticals Inc maintain its current growth ratePortfolio Update Report & Long-Term Investment Growth Plans - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Aug Rallies: Is GIFI a top pick in the sectorQuarterly Profit Review & Daily Momentum Trading Reports - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Rhumbline Advisers Has $4.41 Million Holdings in Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

James C. Hamilton Sells 15,000 Shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Volume Summary: Whats next for BlackRock Health Sciences Trust stockMarket Sentiment Report & Weekly Chart Analysis and Guides - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Big Picture: Whats the beta of Arrowhead Pharmaceuticals Inc stock2025 Price Momentum & Free High Accuracy Swing Entry Alerts - خودرو بانک

Sep 20, 2025
pulisher
Sep 19, 2025

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Acquires 2,774,933 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Aug Outlook: Is Arrowhead Pharmaceuticals Inc stock a top performer YTDQuarterly Market Summary & Real-Time Buy Zone Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Trading Action: What are Arrowhead Pharmaceuticals Incs recent SEC filings showingWatch List & Free Weekly Watchlist of Top Performers - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

What’s the fair value of Xeris Biopharma Holdings Inc. stockMarket Weekly Review & Capital Protection Trading Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Analyst Downgrade: Is Imperial Petroleum Inc stock forming a triangle patternWeekly Stock Report & Long Hold Capital Preservation Tips - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Earnings Report: Is Arrowhead Pharmaceuticals Inc forming a bullish divergence2025 Geopolitical Influence & Comprehensive Market Scan Reports - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Woodline Partners LP - MarketBeat

Sep 19, 2025
pulisher
Sep 18, 2025

Treasury Yields: Will Satellogic Inc Equity Warrant stock benefit from M A2025 Retail Activity & Daily Profit Maximizing Trade Tips - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Arrowhead (ARWR) Climbs 24.9% on $100-Million Licensing Revenue - MSN

Sep 18, 2025
pulisher
Sep 18, 2025

4 Biotech Stocks at the Cutting Edge of Drug Delivery (MDCX, RNA, NBTX, ARWR) - MarketScreener

Sep 18, 2025
pulisher
Sep 18, 2025

Arrowhead Pharmaceuticals : ICW 2025 ARO CFB - MarketScreener

Sep 18, 2025

Arrowhead Pharmaceuticals Inc (ARWR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
大文字化:     |  ボリューム (24 時間):